Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Royal Society 2021 Africa Prize lecture from Professor George Warimwe. More than 70% of emerging infectious diseases (including viruses) are zoonotic, meaning they are acquired from animals, with some causing serious illness and death in humans as well as the animal host. But, what if we could immunise both humans and animals with the same vaccine?

The development and deployment of vaccines against emerging infectious diseases is a priority for global health security. More than 70% of these infectious diseases are zoonotic, meaning they are acquired from animals, with some causing serious illness and death in humans as well as the respective animal host. Despite this, the study of host-pathogen interactions that underlie disease pathogenesis and the mechanisms through which immunity is acquired are often done in medical and veterinary ‘silos’, with little interaction between the two. A ‘one health’ approach that integrates the scientific insights from veterinary and human studies may accelerate progress in the design and development of countermeasures against zoonotic diseases.

Rift Valley Fever, a zoonotic disease that causes epidemics in Africa, is among a shortlist of diseases prioritised by the World Health Organization for urgent development of vaccines. In this talk, Professor George Warimwe will discuss his ‘one health vaccinology’ approach to developing a single Rift Valley Fever vaccine suitable for human and livestock use.

Professor Warimwe's talk is followed by a Q&A chaired by Sir Jeremy James Farrar OBE FRS FMedSci.

Similar stories

Shobhana Nagraj, Women in Science

Clinical Researcher Shobhana Nagraj, from the Health Systems Collaboratives in Oxford, tells us about the female role models who inspired her to follow her dreams

Celebrating Women and Girls in Science

Women have made significant contribution in research despite the numerous challenges they face. To celebrate the women and girls in science we asked some women at KEMRI Wellcome Trust Research programme to share their journey in research, their achievements, and a word of advice to fellow women in science.

VAnguard Launch

KWTRP hosted the launch of the VAnguard research project. The NIHR Funded Project Builds Knowledge-base on Factors Influencing Vaccine Impact among Communities in Kenya and Uganda. The project aims to strengthen collaborations between national and international stakeholders in the identification of social and biological factors that impair vaccine impact in African communities, to develop integrated strategies and recommendations to optimize vaccine impact, and to contribute to health equity in Africa. The launch concurrently took place in Kenya and Uganda from 28th – 30th November 2022.

Abhilasha Karkey, new OUCRU Nepal Director

OUCRU Nepal is pleased to announce that as of 01 October 2022, Dr Abhilasha Karkey will assume the role of Director.

Oxford University named world’s top university for the 7th consecutive year

The University of Oxford has been named the best university in the world for a record seventh consecutive year in the Times Higher Education (THE) World University Rankings 2023.

Four CTMGH researchers awarded full professorships

We are delighted to announce that four of our researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine, University of Oxford.